MDXG News and Press, MiMedx Group Inc From 11/07/18

NEW YORK , Nov. 7, 2018 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600: S&P MidCap 400 constituent Jack Henry & Associates Inc. (NASD: JKHY) will replace EQT Corp. (NYSE: EQT) in t...

The TJX Companies (NYSE: TJX ) -49% . More news on: TJX Companies Inc., MiMedx Group Inc., Infinera Corporation, Stocks on the move, , Top stock market news, Read more ...

The board of MiMedx Group (NASDAQ: MDXG ) has unanimously authorized a limited duration shareholder rights plan that will go into effect at the open tomorrow, November 8, when its common shares will cease trading on Nasdaq. More news on: MiMedx Group Inc., Healthcare stocks news, Stocks ...

MiMedx Group (NASDAQ: MDXG ) slumps  23%  premarket in response to its announcement that Nasdaq will suspend trading in its common stock effective at the open tomorrow, November 8. More news on: MiMedx Group Inc., Healthcare stocks news, Stocks on the move, Read more ...

MARIETTA, Ga. , Nov. 7, 2018 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced that its Board of Directors has unanimously authorized the adoption of a limited duration shareholder rights plan (th...

MARIETTA, Ga. , Nov. 7, 2018 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced that it has received notification from The Nasdaq Stock Market LLC ("Nasdaq") indicating that, as a result of th...

MARIETTA, Ga. , Nov. 6, 2018 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced that five poster abstracts reporting on the Company's EpiFix® dehydrated Human Amnion/Chorion Membrane (dHA...

This article series provides a monthly dashboard of industries in each sector of the GICS classification. It compares valuation and quality factors relative to their historical averages. Executive summary Biotechnology is undervalued regarding historical averages, but profitability measu...

MARIETTA, Ga. , Oct. 31, 2018 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), a leading developer and marketer of regenerative and therapeutic biologics, today announced that five poster abstracts highlighting studies on the Company's EpiFix® dehydrated Human Amnion/Chor...